Using CRISPR/Cas9-based gene editing, we generated Triple Negative Breast Cancer (TNBC) cell lines where endogenous NCL is fused to an AID tag, to promptly control its cellular levels using the phytohormone auxin with unprecedented specificity and temporal resolution. Here, NUCLEOLIN is linked to triple-negative breast carcinoma.